Euromoney Q1 Revenue Up 19%; Buys Boardroom Insiders For $25.0 Mln

Euromoney Institutional Investor Plc (ERM.L), a B2B information services provider, reported that its first quarter revenue was 93.3 million pounds up 19% from last year, while it was up 13% on underlying basis.

The company announced strong start to 2022 with underlying revenue growth in both subscriptions up 8% and events up 53%.

The company said it is well-positioned to deliver results in line with the board's expectations.

The interim results for the six months ending 31 March 2022 will be announced on 19 May 2022.

In a separate press release, Euromoney announced the acquisition of Boardroom Insiders for a cash consideration of $25.0 million.

Boardroom Insiders is a provider of people intelligence to technology companies and professional services. The business has profiles on over 30,000 executives and key decision makers.

The acquisition is expected to be accretive to Euromoney's People Intelligence revenue growth rate and deliver a ROI above the Group's WACC in the second full financial year.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
IBSA Pharma Inc. is recalling 27 lots of TIROSINT-SOL (levothyroxine sodium) Oral Solution to the consumer level due to subpotency, the U.S. Food and Drug Administration said. TIROSINT-SOL is indicated for Hypothyroidism and Pituitary Thyrotropin (Thyroid-Stimulating Hormone, TSH) Suppression. Meanwhile, the recall does not apply to TIROSINT (levothyroxine sodium) capsules. The U.S. Food and Drug Administration approved GlaxoSmithKline LLC's Jesduvroq tablets (daprodustat) for anemia caused by chronic kidney disease or CKD for adults who have been receiving dialysis for at least four months. It is the first oral treatment for anemia, i.e., decreased number of red blood cells, in the given indication that has received FDA approval. German banking major Deutsche Bank AG reported Thursday a significantly higher profit in its fourth quarter and fiscal 2022, mainly reflecting a tax benefit in the U.S, despite weakness in Investment Bank and asset management revenues. The company said it recorded its highest annual profit, both before and after tax, since 2007. However, Deutsche Bank shares were losing around 4 percent...
Follow RTT